Skip to main content
SpringerLink
Log in

TMS in Psychotic Disorders

  • Chapter
  • First Online:
Non Invasive Brain Stimulation in Psychiatry and Clinical Neurosciences

  • 799 Accesses

Abstract

Schizophrenia is one of the most disabling mental disorders with a large burden of disease. Treatment options for positive, negative and cognitive symptoms of schizophrenia are limited, and a third of the patients with schizophrenia respond insufficiently to antipsychotic medications. Over the past decades, researchers have explored new treatment modalities, including neuromodulation with repetitive Transcranial Magnetic Stimulation (rTMS). The available evidence indicates that rTMS can decrease positive and negative symptoms of schizophrenia and may have procognitive effects, although effects may be modest and transient. More research is needed to investigate moderators of effect in order to optimise treatment parameters and thereby establish more durable and clinically relevant effects.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Charlson FJ, Ferrari AJ, Santomauro DF, Diminic S, Stockings E, Scott JG, et al. Global epidemiology and burden of schizophrenia: findings from the global burden of disease study 2016. Schizophr Bull. 2018;44(6):1195–203.

    PubMed  PubMed Central  Google Scholar 

  2. Samara MT, Nikolakopoulou A, Salanti G, Leucht S. How many patients with schizophrenia do not respond to antipsychotic drugs in the short term? An analysis based on individual patient data from randomized controlled trials. Schizophr Bull. 2018;45(3):ss639–46. https://doi.org/10.1093/schbul/sby095.

    Article  Google Scholar 

  3. Buchanan RW. Persistent negative symptoms in schizophrenia: an overview. Schizophr Bull. 2007;33(4):1013–22.

    PubMed  Google Scholar 

  4. Gruber O, Chadha Santuccione A, Aach H. Magnetic resonance imaging in studying schizophrenia, negative symptoms, and the glutamate system. Front Psychiatry. 2014;5:32.

    PubMed  PubMed Central  Google Scholar 

  5. Fusar-Poli P, Papanastasiou E, Stahl D, et al. Treatments of negative symptoms in schizophrenia: metaanalysis of 168 randomized placebo-controlled trials. Schizophr Bull. 2015;41(4):892–9.

    PubMed  Google Scholar 

  6. Dlabac-de Lange JJ, Knegtering R, Aleman A. Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: review and meta-analysis. J Clin Psychiatry. 2010;71(4):411–8.

    PubMed  Google Scholar 

  7. Shi C, Yu X, Cheung EF, Shum DH, Chan RC. Revisiting the therapeutic effect of rTMS on negative symptoms in schizophrenia: a meta-analysis. Psychiatry Res. 2014;215(3):505–13.

    PubMed  Google Scholar 

  8. Slotema CW, Blom JD, Hoek HW, Sommer IE. Should we expand the toolbox of psychiatric treatment methods to include repetitive transcranial magnetic stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders. J Clin Psychiatry. 2010;71(7):873–84.

    PubMed  Google Scholar 

  9. Freitas C, Fregni F, Pascual-Leone A. Meta-analysis of the effects of repetitive transcranial magnetic stimulation (rTMS) on negative and positive symptoms in schizophrenia. Schizophr Res. 2009;108(1–3):11–24.

    PubMed  PubMed Central  Google Scholar 

  10. He H, Lu J, Yang L, Zheng J, Gao F, Zhai Y, et al. Repetitive transcranial magnetic stimulation for treating the symptoms of schizophrenia: a PRISMA compliant meta-analysis. Clin Neurophysiol. 2017;128(5):716–24.

    PubMed  Google Scholar 

  11. Aleman A, Enriquez-Geppert S, Knegtering H, Dlabac-de Lange JJ. Moderate effects of noninvasive brain stimulation of the frontal cortex for improving negative symptoms in schizophrenia: meta-analysis of controlled trials. Neurosci Biobehav Rev. 2018;89:111–8.

    PubMed  Google Scholar 

  12. Kennedy NI, Lee WH, Frangou S. Efficacy of non-invasive brain stimulation on the symptom dimensions of schizophrenia: a meta-analysis of randomized controlled trials. Eur Psychiatry. 2018;49:69–77.

    PubMed  Google Scholar 

  13. Osoegawa C, Gomes JS, Grigolon RB, Brietzke E, Gadelha A, Lacerda ALT, et al. Non-invasive brain stimulation for negative symptoms in schizophrenia: an updated systematic review and meta-analysis. Schizophr Res. 2018;197:34–44.

    PubMed  Google Scholar 

  14. Dlabac-de Lange JJ, Bais L, van Es FD, et al. Efficacy of bilateral repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: results of a multicenter double-blind randomized controlled trial. Psychol Med. 2015;45(6):1263–75.

    CAS  PubMed  Google Scholar 

  15. Hovington CL, Lepage M. Neurocognition and neuroimaging of persistent negative symptoms of schizophrenia. Expert Rev Neurother. 2012;12(1):53–69.

    PubMed  Google Scholar 

  16. Strafella AP, Paus T, Barrett J, Dagher A. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J Neurosci. 2001;21(15):RC157.

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Luborzewski A, Schubert F, Seifert F, et al. Metabolic alterations in the dorsolateral prefrontal cortex after treatment with high-frequency repetitive transcranial magnetic stimulation in patients with unipolar major depression. J Psychiatr Res. 2007;41(7):606–15.

    PubMed  Google Scholar 

  18. Michael N, Gosling M, Reutemann M, et al. Metabolic changes after repetitive transcranial magnetic stimulation (rTMS) of the left prefrontal cortex: a sham-controlled proton magnetic resonance spectroscopy (1H MRS) study of healthy brain. Eur J Neurosci. 2003;17(11):2462–8.

    PubMed  Google Scholar 

  19. Cohen E, Bernardo M, Masana J, et al. Repetitive transcranial magnetic stimulation in the treatment of chronic negative schizophrenia: a pilot study. J Neurol Neurosurg Psychiatry. 1999;67(1):129–30.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. Hajak G, Marienhagen J, Langguth B, Werner S, Binder H, Eichhammer P. High-frequency repetitive transcranial magnetic stimulation in schizophrenia: a combined treatment and neuroimaging study. Psychol Med. 2004;34(7):1157–63.

    CAS  PubMed  Google Scholar 

  21. Jandl M, Bittner R, Sack A, et al. Changes in negative symptoms and EEG in schizophrenic patients after repetitive transcranial magnetic stimulation (rTMS): an open-label pilot study. J Neural Transm. 2005;112(7):955–67.

    CAS  PubMed  Google Scholar 

  22. Guse B, Falkai P, Gruber O, et al. The effect of long-term high frequency repetitive transcranial magnetic stimulation on working memory in schizophrenia and healthy controls--a randomized placebo-controlled, double-blind fMRI study. Behav Brain Res. 2013;237:300–7.

    PubMed  Google Scholar 

  23. Prikryl R, Mikl M, Prikrylova Kucerova H, et al. Does repetitive transcranial magnetic stimulation have a positive effect on working memory and neuronal activation in treatment of negative symptoms of schizophrenia? Neuro Endocrinol Lett. 2012;33(1):90–7.

    PubMed  Google Scholar 

  24. Dlabac-de Lange JJ, Liemburg EJ, Bais L, Renken RJ, Knegtering H, Aleman A. Effect of rTMS on brain activation in schizophrenia with negative symptoms: a proof-of-principle study. Schizophr Res. 2015;168(1–2):475–82.

    PubMed  Google Scholar 

  25. Liemburg EJ, Dlabac-De Lange JJ, Bais L, Knegtering H, Aleman A. Effects of bilateral prefrontal rTMS on brain activation during social-emotional evaluation in schizophrenia: a double-blind, randomized, exploratory study. Schizophr Res. 2018;202:210–1.

    PubMed  Google Scholar 

  26. Dlabac-de Lange JJ, Liemburg EJ, Bais L, van de Poel-Mustafayeva AT, de Lange-de Klerk ESM, Knegtering H, et al. Effect of bilateral prefrontal rTMS on left prefrontal NAA and Glx levels in schizophrenia patients with predominant negative symptoms: an exploratory study. Brain Stimul. 2017;10(1):59–64.

    Google Scholar 

  27. Klein E, Kolsky Y, Puyerovsky M, Koren D, Chistyakov A, Feinsod M. Right prefrontal slow repetitive transcranial magnetic stimulation in schizophrenia: a double-blind sham-controlled pilot study. Biol Psychiatry. 1999;46(10):1451–4.

    CAS  PubMed  Google Scholar 

  28. Holi MM, Eronen M, Toivonen K, Toivonen P, Marttunen M, Naukkarinen H. Left prefrontal repetitive transcranial magnetic stimulation in schizophrenia. Schizophr Bull. 2004;30(2):429–34.

    PubMed  Google Scholar 

  29. Jin Y, Potkin SG, Kemp AS, et al. Therapeutic effects of individualized alpha frequency transcranial magnetic stimulation (alphaTMS) on the negative symptoms of schizophrenia. Schizophr Bull. 2006;32(3):556–61.

    PubMed  Google Scholar 

  30. Novak T, Horacek J, Mohr P, et al. The double-blind sham-controlled study of high-frequency rTMS (20 hz) for negative symptoms in schizophrenia: negative results. Neuro Endocrinol Lett. 2006;27(1–2):209–13.

    PubMed  Google Scholar 

  31. Mogg A, Purvis R, Eranti S, et al. Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: a randomized controlled pilot study. Schizophr Res. 2007;93(1–3):221–8.

    PubMed  Google Scholar 

  32. Prikryl R, Kasparek T, Skotakova S, Ustohal L, Kucerova H, Ceskova E. Treatment of negative symptoms of schizophrenia using repetitive transcranial magnetic stimulation in a double-blind, randomized controlled study. Schizophr Res. 2007;95(1–3):151–7.

    PubMed  Google Scholar 

  33. Goyal N, Nizamie SH, Desarkar P. Efficacy of adjuvant high frequency repetitive transcranial magnetic stimulation on negative and positive symptoms of schizophrenia: preliminary results of a double-blind sham-controlled study. J Neuropsychiatry Clin Neurosci. 2007;19(4):464–7.

    PubMed  Google Scholar 

  34. Fitzgerald PB, Herring S, Hoy K, et al. A study of the effectiveness of bilateral transcranial magnetic stimulation in the treatment of the negative symptoms of schizophrenia. Brain Stimul. 2008;1(1):27–32.

    PubMed  Google Scholar 

  35. Schneider AL, Schneider TL, Stark H. Repetitive transcranial magnetic stimulation (rTMS) as an augmentation treatment for the negative symptoms of schizophrenia: a 4-week randomized placebo controlled study. Brain Stimul. 2008;1(2):106–11.

    PubMed  Google Scholar 

  36. Cordes J, Thunker J, Agelink MW, et al. Effects of 10 hz repetitive transcranial magnetic stimulation (rTMS) on clinical global impression in chronic schizophrenia. Psychiatry Res. 2010;177(1–2):32–6.

    PubMed  Google Scholar 

  37. Barr MS, Farzan F, Tran LC, Fitzgerald PB, Daskalakis ZJ. A randomized controlled trial of sequentially bilateral prefrontal cortex repetitive transcranial magnetic stimulation in the treatment of negative symptoms in schizophrenia. Brain Stimul. 2012;5(3):337–46.

    PubMed  Google Scholar 

  38. Jin Y, Kemp AS, Huang Y, et al. Alpha EEG guided TMS in schizophrenia. Brain Stimul. 2012;5(4):560–8.

    PubMed  Google Scholar 

  39. Zheng L, Guo Q, Li H, Li C, Wang JJ. Effects of repetitive transcranial magnetic stimulation with different paradigms on the cognitive function and psychotic symptoms of schizophrenia patients. Beijing Da Xue Xue Bao. 2012;44:732–6.

    PubMed  Google Scholar 

  40. Prikryl R, Ustohal L, Prikrylova Kucerova H, et al. A detailed analysis of the effect of repetitive transcranial magnetic stimulation on negative symptoms of schizophrenia: a double-blind trial. Schizophr Res. 2013;149(1–3):167–73.

    PubMed  Google Scholar 

  41. Zhao S, Kong J, Li S, Tong Z, Yang C, Zhong H. Randomized controlled trial of four protocols of repetitive transcranial magnetic stimulation for treating the negative symptoms of schizophrenia. Shanghai Arch Psychiatry. 2014;26(1):15–21.

    PubMed  PubMed Central  Google Scholar 

  42. Rabany L, Deutsch L, Levkovitz Y. Double-blind, randomized sham controlled study of deep-TMS add-on treatment for negative symptoms and cognitive deficits in schizophrenia. J Psychopharmacol. 2014;28(7):686–90.

    PubMed  Google Scholar 

  43. Garg S, Sinha VK, Tikka SK, Mishra P, Goyal N. The efficacy of cerebellar vermal deep high frequency (theta range) repetitive transcranial magnetic stimulation (rTMS) in schizophrenia: a randomized rater blind-sham controlled study. Psychiatry Res. 2016;243:413–20.

    PubMed  Google Scholar 

  44. Quan WX, Zhu XL, Qiao H, Zhang WF, Tan SP, Zhou DF, et al. The effects of high-frequency repetitive transcranialmagnetic stimulation (rTMS) on negative symptoms of schizophrenia and the follow-up study. Neurosci Lett. 2015;584:197–201.

    CAS  PubMed  Google Scholar 

  45. Wobrock T, Guse B, Cordes J, et al. Left prefrontal high-frequency repetitive transcranial magnetic stimulation for the treatment of schizophrenia with predominant negative symptoms: a sham-controlled, randomized multicenter trial. Biol Psychiatry. 2015;77(11):979–88.

    PubMed  Google Scholar 

  46. Gan J, Duan H, Chen Z, Shi Z, Gao C, Zhu X, et al. Effectiveness and safety of high dose transcranial magnetic stimulation in schizophrenia with refractory negative symptoms: a randomized controlled study. Zhonghua Yi Xue Za Zhi. 2015;95(47):3808–12.

    PubMed  Google Scholar 

  47. Li Z, Yin M, Lyu XL, Zhang LL, Du XD, Hung GCL. Delayed effect of repetitive transcranial magnetic stimulation (rTMS) on negative symptoms of schizophrenia: findings from a randomized controlled trial. Psychiatry Res. 2016;240:333–5.

    PubMed  Google Scholar 

  48. Hasan A, Falkai P, Wobrock T. Transcranial brain stimulation in schizophrenia: targeting cortical excitability, connectivity and plasticity. Curr Med Chem. 2013;20(3):405–13.

    CAS  PubMed  Google Scholar 

  49. Kamp D, Engelke C, Wobrock T, Wölwer W, Winterer G, Schmidt-Kraepelin C, et al. Left prefrontal high-frequency rTMS may improve movement disorder in schizophrenia patients with predominant negative symptoms—a secondary analysis of a sham-controlled, randomized multicenter trial. Schizophr Res. 2019;204:445–7.

    PubMed  Google Scholar 

  50. Wagner E, Wobrock T, Kunze B, Langguth B, Landgrebe M, Eichhammer P, et al. Efficacy of high-frequency repetitive transcranial magnetic stimulation in schizophrenia patients with treatment-resistant negative symptoms treated with clozapine. Schizophr Res. 2019;208:370–6.

    PubMed  Google Scholar 

  51. Hoffman RE, Boutros NN, Berman RM, Roessler E, Belger A, Krystal JH, Charney DS. Transcranial magnetic stimulation of left temporoparietal cortex in three patients reporting hallucinated “voices”. Biol Psychiatry. 1999;46(1):130–2.

    CAS  PubMed  Google Scholar 

  52. Aleman A, Sommer IE, Kahn RS. Efficacy of slow repetitive transcranial magnetic stimulation in the treatment of resistant auditory hallucinations in schizophrenia: a meta-analysis. J Clin Psychiatry. 2007 Mar;68(3):416–21.

    PubMed  Google Scholar 

  53. Slotema CW, Aleman A, Daskalakis ZJ, Sommer IE. Meta-analysis of repetitive transcranial magnetic stimulation in the treatment of auditory verbal hallucinations: update and effects after one month. Schizophr Res. 2012;142(1–3):40–5.

    CAS  PubMed  Google Scholar 

  54. Hunter MD, Eickhoff SB, Miller TW, Farrow TF, Wilkinson ID, Woodruff PW. Neural activity in speech-sensitive auditory cortex during silence. Proc Natl Acad Sci U S A. 2006;103(1):189–94.

    CAS  PubMed  Google Scholar 

  55. Tracy DK, de Sousa de Abreu M, Nalesnik N, Mao L, Lage C, Shergill SS. Neuroimaging effects of 1 Hz right temporoparietal rTMS on normal auditory processing: implications for clinical hallucination treatment paradigms. J Clin Neurophysiol. 2014;31(6):541–6.

    PubMed  Google Scholar 

  56. Bais L, Liemburg E, Vercammen A, Bruggeman R, Knegtering H, Aleman A. Effects of low frequency rTMS treatment on brain networks for inner speech in patients with schizophrenia and auditory verbal hallucinations. Prog Neuro-Psychopharmacol Biol Psychiatry. 2017;78:105–13.

    Google Scholar 

  57. Hoffman RE, Hampson M, Wu K, Anderson AW, Gore JC, Buchanan RJ, Constable RT, Hawkins KA, Sahay N, Krystal JH. Probing the pathophysiology of auditory/verbal hallucinations by combining functional magnetic resonance imaging and transcranial magnetic stimulation. Cereb Cortex. 2007;17(11):2733–43.

    PubMed  PubMed Central  Google Scholar 

  58. Koops S, Slotema CW, Kos C, Bais L, Aleman A, Blom JD, Sommer IEC. Predicting response to rTMS for auditory hallucinations: younger patients and females do better. Schizophr Res. 2018;195:583–4.

    PubMed  Google Scholar 

  59. Nathou C, Simon G, Dollfus S, Etard O. Cortical anatomical variations and efficacy of rTMS in the treatment of auditory hallucinations. Brain Stimul. 2015;8(6):1162–7.

    PubMed  Google Scholar 

  60. Cheeran B, Talelli P, Mori F, Koch G, Suppa A, Edwards M, Houlden H, Bhatia K, Greenwood R, Rothwell JC. A common polymorphism in the brain-derived neurotrophic factor gene (BDNF) modulates human cortical plasticity and the response to rTMS. J Physiol. 2008;586(23):5717–25.

    CAS  PubMed  PubMed Central  Google Scholar 

  61. Bocchio-Chiavetto L, Miniussi C, Zanardini R, Gazzoli A, Bignotti S, Specchia C, Gennarelli M. 5-HTTLPR and BDNF Val66Met polymorphisms and response to rTMS treatment in drug resistant depression. Neurosci Lett. 2008;437(2):130–4.

    CAS  PubMed  Google Scholar 

  62. Hasan A, Guse B, Cordes J, Wölwer W, Winterer G, Gaebel W, et al. Cognitive effects of high-frequency rTMS in schizophrenia patients with predominant negative symptoms: results from a multicenter randomized sham-controlled trial. Schizophr Bull. 2016;42(3):608–18.

    PubMed  Google Scholar 

  63. Mittrach M, Thünker J, Winterer G, Agelink MW, Regenbrecht G, Arends M, et al. The tolerability of rTMS treatment in schizophrenia with respect to cognitive function. Pharmacopsychiatry. 2010;43(3):110–7.

    CAS  PubMed  Google Scholar 

  64. Francis MM, Hummer TA, Vohs JL, Yung MG, Visco AC, Mehdiyoun NF, et al. Cognitive effects of bilateral high frequency repetitive transcranial magnetic stimulation in early phase psychosis: a pilot study. Brain Imaging Behav. 2019;13(3):852–61.

    PubMed  Google Scholar 

  65. Rollnik JD, Huber TJ, Mogk H, Siggelkow S, Kropp S, Dengler R, et al. High frequency repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex in schizophrenic patients. Neuroreport. 2000;11(18):4013–5.

    CAS  PubMed  Google Scholar 

  66. Jiang Y, Guo Z, Xing G, He L, Peng H, Du F, et al. Effects of high-frequency transcranial magnetic stimulation for cognitive deficit in schizophrenia: a meta-analysis. Front Psych. 2019;10:135.

    Google Scholar 

  67. Barr MS, Farzan F, Arenovich T, Chen R, Fitzgerald PB, Daskalakis ZJ. The effect of repetitive transcranial magnetic stimulation on gamma oscillatory activity in schizophrenia. PLoS One. 2011;6(7):e22627.

    CAS  PubMed  PubMed Central  Google Scholar 

  68. Barr MS, Farzan F, Rajji TK, Voineskos AN, Blumberger DM, Arenovich T, et al. Can repetitive magnetic stimulation improve cognition in schizophrenia? Pilot data from a randomized controlled trial. Biol Psychiatry. 2013;73(6):510–7.

    PubMed  Google Scholar 

  69. Wölwer W, Lowe A, Brinkmeyer J, Streit M, Habakuck M, Agelink MW, et al. Repetitive transcranial magnetic stimulation (rTMS) improves facial affect recognition in schizophrenia. Brain Stimul. 2014;7(4):559–63.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

    Andre Aleman & Jozarni Dlabac-de Lange

Authors
  1. Andre Aleman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jozarni Dlabac-de Lange
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andre Aleman .

Editor information

Editors and Affiliations

  1. ASST Fatebenefratelli Sacco, University of Milan, MILANO, Milano, Italy

    Bernardo Dell'Osso

  2. University of Rome Tor Vergata, Roma, Italy

    Giorgio Di Lorenzo

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Aleman, A., Lange, J.Dd. (2020). TMS in Psychotic Disorders. In: Dell'Osso, B., Di Lorenzo, G. (eds) Non Invasive Brain Stimulation in Psychiatry and Clinical Neurosciences. Springer, Cham. https://doi.org/10.1007/978-3-030-43356-7_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-43356-7_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-43355-0

  • Online ISBN: 978-3-030-43356-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation